Co-Doping of Cerium and Bismuth into Lead-Free Double Perovskite Cs2AgInCl6 Nanocrystals Results in Improved Photoluminescence Efficiency.

Lead-free double cation metal halide perovskites have recently attracted considerable attention, with continuing research efforts focusing on the improvement of their stability and photoluminescence quantum yield (PL QY). In this study, Ce3+ has been co-doped together with Bi3+ into lead-free double perovskite Cs2AgInCl6 nanocrystals (NCs) in order to improve their crystallinity and PL QY. Both uncoordinated chloride ions and silver vacancies could be eliminated using this co-doping strategy, and the resulting Ce3+,Bi3+-co-doped Cs2AgInCl6 NCs showed adjustable PL emission peaks in the range of 589 to 577 nm by varying the doping amount of Ce3+ with a fixed feeding ratio of bismuth precursor set at 1%. Cs2AgInCl6 NCs doped with 1% Bi alone reached a PL QY of 10% for the PL peak centered at 591 nm, while those co-doped with 1% Bi and 2% Ce together achieved the highest PL QY of 26% for the PL peak centered at 580 nm. The use of Ce3+ as a dopant promoted the localization of self-trapped excitons to prevent PL quenching, although the ion's 5d excited state may potentially provide an energetically favorable indirect route for the radiative relaxation process. This also resulted in a blue shift of the PL maximum and increased the exciton binding energy, thus promoting the radiative recombination of self-trapped excitons.

Room Temperature Fabrication of Stable, Strongly Luminescent Dion-Jacobson Tin Bromide Perovskite Microcrystals Achieved through Use of Primary Alcohols.

Lead-free two-dimensional metal halide perovskites have recently emerged as promising light-emitting materials due to their improved stability and attractive optical properties. Herein, a facile room temperature wet milling method has been developed to make Dion-Jacobson (DJ) phase ODASnBr4 perovskite microcrystals, whose crystallization was accomplished via the aid of introduced primary alcohols: ethanol, butanol, pentanol, and hexanol. Due to the strong intermolecular hydrogen bonding, the use of ethanol promoted the formation of non-doped ODASnBr4 microcrystals, with an emission peaked at 599 nm and a high photoluminescence quantum yield (PL QY) of 81%. By introducing other primary alcohols with weaker intermolecular hydrogen bonding such as butanol, pentanol, and hexanol, [SnBr6]4- octahedral slabs of the DJ perovskite microcrystals experienced various degrees of expansion while forming O-H…Br hydrogen bonds. This resulted in the emission spectra of these alcohol-doped microcrystals to be adjusted in the range from 572 to 601 nm, while keeping the PL QY high, at around 89%. Our synthetic strategy provides a viable pathway towards strongly emitting lead-free DJ perovskite microcrystals with an improved stability.

Interplay between the Gut Microbiome and Metabolism in Ulcerative Colitis Mice Treated with the Dietary Ingredient Phloretin.

A growing number of healthy dietary ingredients in fruits and vegetables have been shown to exhibit diverse biological activities. Phloretin, a dihydrochalcone flavonoid that is abundant in apples and pears, has anti-inflammatory effects on ulcerative colitis (UC) mice. The gut microbiota and metabolism are closely related to each other due to the existence of the food-gut axis in the human colon. To investigate the interplay of faecal metabolites and the microbiota in UC mice after phloretin treatment, phloretin (60 mg/kg) was administered by gavage to ameliorate dextran sulfate sodium (DSS)-induced UC in mice. Gut microbes and faecal metabolite profiles were detected by high-throughput sequencing and liquid chromatography mass spectrometry (LC-MS) analysis, respectively. The correlations between gut microbes and their metabolites were evaluated by Spearman correlation coefficients. The results indicated that phloretin reshaped the disturbed faecal metabolite profile in UC mice and improved the metabolic pathways by balancing the composition of faecal metabolites such as norepinephrine, mesalazine, tyrosine, 5-acetyl-2,4-dimethyloxazole, and 6-acetyl-2,3-dihydro-2-(hydroxymethyl)-4(1H)-pyridinone. Correlation analysis identified the relations between the gut microbes and their metabolites. Proteus was negatively related to many faecal metabolites, such as norepinephrine, L-tyrosine, laccarin, dopamine glucuronide, and 5-acetyl-2,4-dimethyloxazole. The abundance of unidentified Bacteriodales_S24-7_group was positively related to ecgonine, 15-KETE and 6-acetyl-2,3-dihydro-2-(hydroxymethyl)-4(1H)-pyridinone. The abundance of Christensenellaceae_R-7_group was negatively related to the levels of 15-KETE and netilmicin. Stenotrophomonas and 15-KETE were negatively related, while Intestinimonas and alanyl-serine were positively related. In conclusion, phloretin treatment had positive impacts on faecal metabolites in UC mice, and the changes in faecal metabolites were closely related to the gut microbiota.

Transarterial oily chemoembolization with lidamycin shows potent therapeutic efficacy in VX2 rabbit liver tumor.

Transarterial oily chemoembolization (TOCE) is one of the most effective approaches for the treatment of patients with hepatocellular carcinoma (HCC), who are not suitable for surgical therapy. Lidamycin (LDM), a potent antitumor antibiotic, demonstrates good antitumor efficacy in various tumor types, both in vitro and in vivo. In this study, the antitumor efficacy of LDM combined with TOCE against the rabbit VX2 tumor was assessed. A toxicity assay with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) demonstrated that a combination of LDM with lipiodol did not impair the cytotoxicity of LDM against HepG2 cells in vitro. Using TOCE in rabbit VX2 tumor models, LDM showed a more powerful inhibitory effect against the tumor and lowered the expression levels of proliferating cell nuclear antigen (PCNA), cluster of differentiation 31 (CD31), and vascular endothelial growth factor (VEGF) compared to Adriamycin (ADM); moreover, this improvement was not accompanied by an increase of hepatotoxicity as shown by alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels. These results suggested that LDM combined with TOCE may be a feasible strategy in HCC therapy in the future.

Combination of interventional adenovirus-p53 introduction and ultrasonic irradiation in the treatment of liver cancer.

The aim of the present study was to investigate the effect of the combination of interventional adenovirus-p53 (Ad-p53) introduction and ultrasonic irradiation (CIAIUI) treatment for liver cancer, including evaluating the Ad-p53 transfection efficiency and the impact of the p53 gene on vascular endothelial growth factor (VEGF) and matrix metalloprotein 2 (MMP2) protein expression levels. Ad-p53 was arterially infused into the hepatic carcinoma via the interventional introduction of the hepatic tumor-bearing artery (IIHTBA) or the CIAIUI. Serum VEGF levels were determined by performing an enzyme-linked immunosorbent assay; immunohistochemical analysis was used to identify the expression levels of intratumoral p53, MMP2 and VEGF; and western blot analysis was used to determine the impact of different Ad-p53 administration methods on the expression of wild-type p53. The wild-type p53 expression level was significantly higher in the p53-treated group compared with the control group, and the p53 expression level in the CIAIUI group was significantly higher compared with the non-irradiation group. The CIAIUI could significantly reduce the serum VEGF levels. The two delivery methods caused a reduction in the intratumoral VEGF and MMP2 expression levels, and the effects of CIAIUI were most obvious. Ad-p53 infusion via IIHTBA promoted the protein expression levels of p53, however, it inhibited the protein expression levels of MMP2 and VEGF, indirectly indicating that the gene may inhibit the growth of liver cancer. Therefore, CIAIUI therapy exhibited an overall improved therapeutic effect compared with the more simple IIHTBA therapy.

MicroRNA-194 acts as a prognostic marker and inhibits proliferation in hepatocellular carcinoma by targeting MAP4K4.

MicroRNAs (miRNAs) play a crucial role in cancer development and progression of hepatocellular carcinoma (HCC). In this study, we aimed to analyze the role of microRNA-194 (miR-194) in HCC. We found that miR-194 expression was significantly reduced in HCC and its expression was an independent poor prognostic factor for HCC patient overall and disease-free survival rate. A significant correlation was observed between miR-194 reduction and unfavourable variables including tumor size (P = 0.0315), histologic grade (P = 0.0038), TNM stage (P = 0.0083), intrahepatic metastasis (P = 0.0184). Overexpression of miR-194 in HCC cell lines HepG2 and Hep3B inhibited cell proliferation by blocking G1-S transition and inducing apoptosis. Mitogen-activated protein kinase 4 (MAP4K4), a potential target gene of miR-194, was inversely correlated with miR-194 expression in HCC tissues and cell lines. Further studies demonstrated that miR-194 regulated the progression of HCC through directly inhibiting the expression of MAP4K4 and the restoration of MAP4K4 expression reversed the inhibitory effects of miR-194 on HCC cell proliferation. Together, our findings indicate that miR-194 may serve as a valuable prognostic marker and promising interventional therapeutic target for HCC.